Roche Holding Ltd. (ROG) PT Set at CHF 279 by Liberum Capital
Roche Holding Ltd. (VTX:ROG) has been given a CHF 279 target price by analysts at Liberum Capital in a research note issued to investors on Wednesday. The brokerage currently has a “buy” rating on the healthcare company’s stock. Liberum Capital’s price target would suggest a potential upside of 13.09% from the stock’s current price.
Other analysts have also issued reports about the stock. J P Morgan Chase & Co reiterated a “buy” rating and issued a price target on shares of Roche Holding in a research note on Friday, July 28th. Sanford C. Bernstein set a CHF 284 price target on shares of Roche Holding and gave the stock a “buy” rating in a research note on Thursday, July 27th. Goldman Sachs Group, Inc. (The) set a CHF 335 price target on shares of Roche Holding and gave the stock a “buy” rating in a research note on Thursday, August 24th. Berenberg Bank set a CHF 273 price target on shares of Roche Holding and gave the stock a “buy” rating in a research note on Tuesday, August 15th. Finally, Credit Suisse Group set a CHF 300 price objective on shares of Roche Holding and gave the stock a “buy” rating in a report on Monday, September 11th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of CHF 261.78.
Shares of Roche Holding (VTX:ROG) opened at CHF 246.70 on Wednesday. Roche Holding has a 12 month low of CHF 218.30 and a 12 month high of CHF 273.
About Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.